3,4-Methylenedioxy-N-hydroxyamphetamine


3,4-Methylenedioxy-N-hydroxyamphetamine, also known as N-hydroxy-MDA, is an entactogen, psychedelic, and stimulant of the phenethylamine, amphetamine, and MDxx families. It is the N-hydroxy homologue of MDA, and the N-desmethyl homologue of FLEA.

Use and effects

In his book PiHKAL, Alexander Shulgin listed the dose range as 100 to 160mg orally and its duration as approximately 3 to 6hours. He describes MDOH as being very psychedelic and producing increased pleasure in beauty and nature. Shulgin also mentioned several negative side effects also seen with MDMA such as difficulty urinating and internal dryness. He has noted that the properties and effects of MDOH are very similar or near-identical to those of MDA and that MDOH might be converted into MDA in the body.

Interactions

Chemistry

Synthesis

The chemical synthesis of MDOH has been described.

Analogues

s of MDOH include MDA and FLEA, among others.

Society and culture

Legal status

Canada

MDOH is a controlled substance in Canada.

United States

MDOH is a schedule I controlled substance in the United States.